Elevated IGF-1 has implications for patients with certain health histories
Those who consume this formula can feel fuller for a longer period, have lower blood sugar spikes after meals, and burn fat more efficiently
Together, these findings underscore the power of personalized, continuous remote care to support durable and scalable weight loss outcomes #ObesityWeek #OW2025 #Obesity #Telemedicine #ClinicallyMeaningfulWeightLoss #GLP1 #IncretinMimetics #Realworld To view or add a comment, sign in Excited to share our latest JAMA Internal Medicine Guide to Statistics by Til Strmer and Tiansheng Wang, focusing on "Semaglutide vs Tirzepatide for Weight Loss in Adults With Overweight or Obesity." This guide breaks down the study's design, analytic approach, and key takeaways, enhancing accessibility for clinicians and researchers
Semaglutide on Long-Term Outcomes in Heart Failure Patients with co-existing chronic kidney disease: A US Cohort Propensity-Matched Study Saturday, May 3, 2025
The synergy was also evident in drug-resistant MTB strains
Why is prior authorization so common for semaglutide weight-loss coverage